Join to View Full Profile
West 52nd StreetNew York, NY 10019
Phone+1 415-307-9691
Dr. Venstrom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2010
Johns Hopkins UniversityResidency, Internal Medicine, 2004 - 2006
Vanderbilt University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2010 - 2016
NY State Medical License 2006 - 2011
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701 Start of enrollment: 2010 Feb 01
- Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 1 citationsA Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease.Brandon A Mahal, Matthew Margolis, Earl Hubbell, Cheng Chen, Jeffrey M Venstrom
JCO Precision Oncology. 2024-08-01 - 2 citationsThe Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer.Will H Jin, Liangliang Zhang, Ryon Graf, Kira Raskina, Hanna Tukachinsky
Clinical Genitourinary Cancer. 2024-02-01 - 2 citationsLong-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-m...Camille Laurent, Maria Flores, Loïc Chartier, Sarah Huet, Christopher R Bolen
British Journal of Haematology. 2023-08-01
Abstracts/Posters
- Recapitulation of Prognostic Mutational Subtyping Utilizing F1H in GOYA and CAVALLI and the Potential to Highlight Benefit of Targeted Therapy in De Novo DLBCLJeffrey M. Venstrom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Molecular Characteristics and Disease Burden Metrics Determined By Next-Generation Sequencing on Circulating Tumor DNA Correlate with Progression Free Survival in Prev...Jeffrey M. Venstrom, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Resistance of Natural Killer and T Cells to Venetoclax Allows for Combination Treatment with Cancer Immunotherapy Agents2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Prediction and Characterization of Diffuse Large B-Cell Lymphoma (DLBCL) Cell of Origin (COO) Subtypes Using Genomic Features from Targeted Next-Generation Sequencing2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Providence and GRAIL Expand Partnership to Increase Access to Galleri® Multi-Cancer Early Detection ScreeningApril 4th, 2023- Detecting Cancers Through Blood Tests Holds Promise, but Major Hurdles RemainSeptember 25th, 2022
- Study: Blood Test Can ID Cancers Without Clear SymptomsSeptember 13th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
